doi:10.1016/j.biocel.2003.08.002. PMID 15147718. “Factor V Leiden, prothrombinG20210A substitution and hormone therapy: indications for molecular screening”
「最速!聖路加診断術」, pp.15-22. ^ Ro A, et al. The factor V Leiden mutation and the prothrombinG20210A mutation was not found in Japanese patients with pulmonary thromboembolism
thromboembolism among heterozygous carriers of factor V Leiden or prothrombinG20210A mutation. A systematic review of prospective studies”. Haematologica